Samrat Pharmachem Ltd vs Zenotech Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 211.1 as of 30 Apr 15:30 . The P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 yearsThe P/E Ratio of Zenotech Laboratories Ltd changed from 13.9 on March 2022 to 56.4 on March 2025 . This represents a CAGR of 41.93% over 4 years The Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 yearsThe Market Cap of Zenotech Laboratories Ltd changed from ₹ 213.61 crore on March 2021 to ₹ 316.87 crore on March 2025 . This represents a CAGR of 8.21% over 5 years The revenue of Samrat Pharmachem Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 63.83 crore. This represent the decline of -100% The revenue of Zenotech Laboratories Ltd for the Mar '26 is ₹ 10.53 crore as compare to the Dec '25 revenue of ₹ 13.28 crore. This represent the decline of -20.71% The ebitda of Samrat Pharmachem Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the decline of -100% The ebitda of Zenotech Laboratories Ltd for the Mar '26 is ₹ 0.82 crore as compare to the Dec '25 ebitda of ₹ 4.39 crore. This represent the decline of -81.32% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Zenotech Laboratories Ltd changed from ₹ 1.29 crore to ₹ -3.15 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 yearsThe Dividend Payout of Zenotech Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

About Zenotech Laboratories Ltd

Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f.
August 9, 2004.
Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables.
Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s.
Zenotech Technologies Limited with effect from November 1st , 2003.

FAQs for the comparison of Samrat Pharmachem Ltd and Zenotech Laboratories Ltd

Which company has a larger market capitalization, Samrat Pharmachem Ltd or Zenotech Laboratories Ltd?

Market cap of Samrat Pharmachem Ltd is 65 Cr while Market cap of Zenotech Laboratories Ltd is 266 Cr

What are the key factors driving the stock performance of Samrat Pharmachem Ltd and Zenotech Laboratories Ltd?

The stock performance of Samrat Pharmachem Ltd and Zenotech Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samrat Pharmachem Ltd and Zenotech Laboratories Ltd?

As of May 4, 2026, the Samrat Pharmachem Ltd stock price is INR ₹211.1. On the other hand, Zenotech Laboratories Ltd stock price is INR ₹43.61.

How do dividend payouts of Samrat Pharmachem Ltd and Zenotech Laboratories Ltd compare?

To compare the dividend payouts of Samrat Pharmachem Ltd and Zenotech Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.